These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28833338)

  • 1. Reptin regulates insulin-stimulated Akt phosphorylation in hepatocellular carcinoma via the regulation of SHP-1/PTPN6.
    Raymond AA; Javary J; Breig O; Neaud V; Rosenbaum J
    Cell Biochem Funct; 2017 Aug; 35(6):289-295. PubMed ID: 28833338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
    Raymond AA; Benhamouche S; Neaud V; Di Martino J; Javary J; Rosenbaum J
    PLoS One; 2015; 10(4):e0123333. PubMed ID: 25875766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin.
    Breig O; Yates M; Neaud V; Couchy G; Grigoletto A; Lucchesi C; Prox J; Zucman-Rossi J; Becker-Pauly C; Rosenbaum J
    Oncotarget; 2017 Jan; 8(5):7839-7851. PubMed ID: 27999200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence.
    Ménard L; Taras D; Grigoletto A; Haurie V; Nicou A; Dugot-Senant N; Costet P; Rousseau B; Rosenbaum J
    J Hepatol; 2010 May; 52(5):681-9. PubMed ID: 20346530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATPase activity of reptin is required for its effects on tumor cell growth and viability in hepatocellular carcinoma.
    Grigoletto A; Neaud V; Allain-Courtois N; Lestienne P; Rosenbaum J
    Mol Cancer Res; 2013 Feb; 11(2):133-9. PubMed ID: 23233483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.
    Tai WT; Hung MH; Chu PY; Chen YL; Chen LJ; Tsai MH; Chen MH; Shiau CW; Boo YP; Chen KF
    Oncotarget; 2016 Apr; 7(16):22193-205. PubMed ID: 26959741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma.
    Rousseau B; Ménard L; Haurie V; Taras D; Blanc JF; Moreau-Gaudry F; Metzler P; Hugues M; Boyault S; Lemière S; Canron X; Costet P; Cole M; Balabaud C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J
    Hepatology; 2007 Oct; 46(4):1108-18. PubMed ID: 17657734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
    Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
    Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
    Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism.
    Haurie V; Ménard L; Nicou A; Touriol C; Metzler P; Fernandez J; Taras D; Lestienne P; Balabaud C; Bioulac-Sage P; Prats H; Zucman-Rossi J; Rosenbaum J
    Hepatology; 2009 Dec; 50(6):1871-83. PubMed ID: 19877184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF; Su JC; Liu CY; Huang JW; Chen KC; Chen WL; Tai WT; Shiau CW
    Cancer Lett; 2012 Aug; 321(1):27-35. PubMed ID: 22465052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Samarin J; Laketa V; Malz M; Roessler S; Stein I; Horwitz E; Singer S; Dimou E; Cigliano A; Bissinger M; Falk CS; Chen X; Dooley S; Pikarsky E; Calvisi DF; Schultz C; Schirmacher P; Breuhahn K
    Hepatology; 2016 Mar; 63(3):813-26. PubMed ID: 26901106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.